IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells.
AUTOR(ES)
Herlyn, D
RESUMO
Monoclonal antibodies of IgG2a isotype specifically inhibited growth of human tumors in nude mice. Twenty-three monoclonal antibodies of other isotypes showed no tumoricidal reactivity. Complement depletion of nude mice had no effect on tumor suppression by monoclonal antibody. The role of T and killer cells as mediators of the monoclonal antibody effect in nude mice was virtually excluded. On the other hand, macrophages were strongly incriminated as effector cells because silica treatment of nude mice abolished the tumoricidal effect of monoclonal antibody. IgG2a monoclonal antibody-dependent macrophage-mediated cytotoxicity assays with human tumor cells in culture resulted in specific lysis of tumor cells.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=346757Documentos Relacionados
- Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificity.
- Production of human monoclonal IgG antibodies against Rhesus (D) antigen.
- The anti-IRBP IgG1 and IgG2a response does not correlate with susceptibility to experimental autoimmune uveitis
- Antitumor effects of L6, an IgG2a antibody that reacts with most human carcinomas.
- Hypogammaglobulinemia associated with accelerated catabolism of IgG secondary to its interaction with an IgG-reactive monoclonal IgM
